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Background

Images

Molecular Breast Imaging (MBI) is increasingly being used as an
adjunct imaging modality in the detection of breast cancer. 1 A
meta-analysis in 2013 from 8 studies, including 2183 lesions,
showed that the sensitivity and specificity of MBI were 95% and
80%, respectively. 2 Patients received an intravenous injection of
Tc-99m-sestamibi, and a gamma camera was used to obtain
Craniocaudal (CC) and mediolateral oblique (MLO) projections.
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Methods

A retrospective review was performed on 193 suspicious
findings from 153 women (31-81 years) with positive MBI
examinations. We assessed associations between:
(i) Lesion pattern (mass vs. non-mass) and positive predictive
value (PPV)
(ii) Lesion pattern and suspected likelihood of cancer (low vs.
moderate vs. high)
(iii) Background parenchymal uptake (BPU) (homogeneous vs.
heterogeneous) and PPV
(iv) Breast density (dense vs. non-dense) and PPV
(v) BPU and density

Ductal carcinoma in situ
Invasive ductal carcinoma
Invasive ductal carcinoma with a
component of ductal carcinoma in situ
Invasive lobular carcinoma
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High-risk Types
Atypical ductal hyperplasia
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Papillomatosis
Radial Scar
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110/153 patients were diagnosed with malignant or high-risk
pathology (PPV1 = 71.9%), and 130/193 biopsies resulted in
malignant or high-risk lesions (PPV3 = 67.4%).
(i) Biopsies of mass vs. non-mass findings had comparable PPV3
(71.7% vs. 61.3%; P = 0.0717).
(ii) Mass findings were correlated with higher suspicion for
cancer than non-mass findings (P < 0.001).
(iii) There was no significant difference in PPV3 between
biopsies from homo vs. hetero BPU (72.5% vs. 60.7%; P =
0.103). No association was found between BPU and the
diagnosis of cancer or high-risk pathology (P = 0.513).
(iv) Biopsies from non-dense breasts had higher PPV3 than from
dense breasts (85.4% vs 60.6%; P = 0.0025); patients with
non-dense breasts were more likely to yield cancer or highrisk pathology (PPV1 = 87.8% vs. 66.0%; P = 0.00844).
(v) Dense breasts had greater association with heterogeneous
BPU (P = 0.0844) than non-dense breasts.

Conclusion

Table 1 - Pathology of Malignant and High-risk Lesions Detected
Using MBI

Malignant Types

Results

Figure 1A – 80-year-old woman with a mass lesion on homogeneous BPU,
diagnosed as ductal carcinoma in situ in the right breast.
Figure 1B – 53-year-old woman with a mass lesion on heterogeneous BPU,
diagnosed as invasive ductal carcinoma on the right breast.
Figure 1C – 68-year-old woman with a non-mass lesion on homogeneous
BPU, diagnosed with invasive ductal carcinoma with a component of
ductal carcinoma in situ on the left breast.
Figure 1D – 48-year-old woman with a non-mass lesion on heterogeneous
BPU, diagnosed as invasive ductal carcinoma with a component of ductal
carcinoma in situ on the right breast.

Understanding PPV of MBI in correlation to the character of
lesions, BPU, and breast density provides a useful
framework for interpretation and risk-stratification. Our
study demonstrated that variability in mass or non-mass
character of positive MBI findings may affect clinical
suspicion but was not a useful determinant for probability of
malignancy. Additionally, homogeneous vs. heterogeneous
BPU did not significantly affect predictability of positive MBI
images. Lastly, dense breasts yielded more false positives,
likely due to the association with heterogeneous BPU.
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